[Consensus of Chinese experts on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2021)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Mar 14;42(3):185-192. doi: 10.3760/cma.j.issn.0253-2727.2021.03.002.
Abstract
摘要
相似文献
1
[Consensus of Chinese experts on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2021)].《中国血液病患者药物性肝损伤防治与规范化治疗专家共识（2021年版）》
Zhonghua Xue Ye Xue Za Zhi. 2021 Mar 14;42(3):185-192. doi: 10.3760/cma.j.issn.0253-2727.2021.03.002.
2
[Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2016)].[血液系统疾病患者药物性肝损伤预防及规范化治疗专家共识（2016年）]
Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):441-52. doi: 10.3760/cma.j.issn.0253-2727.2016.06.001.
3
[Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases].[血液系统疾病患者药物性肝损伤预防及规范化治疗专家共识声明]
Zhonghua Xue Ye Xue Za Zhi. 2012 Mar;33(3):252-6.
4
[Chinese expert consensus on diagnosis and treatment of antirheumatic drug-induced liver injury(2024)].
Zhonghua Nei Ke Za Zhi. 2024 Aug 1;63(8):743-761. doi: 10.3760/cma.j.cn112138-20240418-00248.
5
[Interpretation on Consensus on drug-induced liver injury by CIOMS Working Group:liver injury attributed to herbal and dietary supplements].[国际医学科学组织委员会（CIOMS）工作组关于药物性肝损伤的共识解读：草药和膳食补充剂所致肝损伤]
Zhongguo Zhong Yao Za Zhi. 2023 May;48(9):2552-2556. doi: 10.19540/j.cnki.cjcmm.20230123.501.
6
Efficacy of Jian'ganle () versus Hugan Pian (), glucuronolactone and reduced glutathione in prevention of antituberculosis drug-induced liver injury.健肝乐（）与护肝片（）、葡萄糖醛酸内酯及还原型谷胱甘肽在预防抗结核药物性肝损伤方面的疗效比较 。
你提供的原文中括号部分内容缺失，我按照正常内容翻译，若你有补充可随时告诉我，以便我为你生成更准确的译文 。
J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):450-455. doi: 10.1007/s11596-014-1299-8. Epub 2014 Jun 18.
7
[Ticlopidine: blood and liver involvement?].噻氯匹定：与血液及肝脏有关？
Therapie. 1982 Mar-Apr;37(2):222-4.
8
Influence of etretinate on blood and liver in rats.依曲替酯对大鼠血液及肝脏的影响。
Jpn J Pharmacol. 1982 Dec;32(6):1175-8. doi: 10.1254/jjp.32.1175.
9
The reply.回复。
Am J Med. 2014 Sep;127(9):e27. doi: 10.1016/j.amjmed.2014.04.037.
10
The reply.回复。
Am J Med. 2014 Sep;127(9):e23-4. doi: 10.1016/j.amjmed.2014.04.036.
引用本文的文献
1
Development and validation of an interpretable machine learning model for predicting Philadelphia chromosome-positive acute lymphoblastic leukaemia using clinical and laboratory parameters: a single-centre retrospective study.利用临床和实验室参数预测费城染色体阳性急性淋巴细胞白血病的可解释机器学习模型的开发与验证：一项单中心回顾性研究
BMJ Open. 2025 Jun 27;15(6):e097526. doi: 10.1136/bmjopen-2024-097526.
本文引用的文献
1
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.泊沙康唑与伏立康唑治疗侵袭性曲霉病的随机对照 3 期非劣效临床试验
Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140-6736(21)00219-1.
2
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.多发性骨髓瘤，第 3.2021 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685-1717. doi: 10.6004/jnccn.2020.0057.
3
Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation.乙型肝炎病毒（HBV）感染再激活的预防——预防HBV再激活工作组的建议
Clin Exp Hepatol. 2019 Sep;5(3):195-202. doi: 10.5114/ceh.2019.87631. Epub 2019 Sep 5.
4
Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: A phase II trial.异甘草酸镁注射液治疗药物性肝损伤的随机、双盲、安慰剂对照Ⅱ期临床研究
Liver Int. 2019 Nov;39(11):2102-2111. doi: 10.1111/liv.14204. Epub 2019 Aug 21.
5
Drug-Induced Liver Injury - Types and Phenotypes.药物性肝损伤——类型与表型
N Engl J Med. 2019 Jul 18;381(3):264-273. doi: 10.1056/NEJMra1816149.
6
EASL Clinical Practice Guidelines: Drug-induced liver injury.EASL 临床实践指南：药物性肝损伤。
J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.
7
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.中国内地药物性肝损伤的发生率及病因学。
Gastroenterology. 2019 Jun;156(8):2230-2241.e11. doi: 10.1053/j.gastro.2019.02.002. Epub 2019 Feb 8.
8
Recent Advances in HBV Reactivation Research.HBV 再激活研究的最新进展。
Biomed Res Int. 2018 Dec 26;2018:2931402. doi: 10.1155/2018/2931402. eCollection 2018.
9
A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China.在中国住院患者中进行的一项多中心、双盲、随机对照研究，比较替加环素与亚胺培南/西司他丁治疗复杂性腹腔内感染的疗效和安全性。
Ther Clin Risk Manag. 2018 Nov 30;14:2327-2339. doi: 10.2147/TCRM.S171821. eCollection 2018.
10
CSH guidelines for the diagnosis and treatment of drug-induced liver injury.药物性肝损伤诊断和治疗的英国肝脏研究学会指南。
Hepatol Int. 2017 May;11(3):221-241. doi: 10.1007/s12072-017-9793-2. Epub 2017 Apr 12.
Zotero 插件